[go: up one dir, main page]

AU7222598A - Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants - Google Patents

Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants

Info

Publication number
AU7222598A
AU7222598A AU72225/98A AU7222598A AU7222598A AU 7222598 A AU7222598 A AU 7222598A AU 72225/98 A AU72225/98 A AU 72225/98A AU 7222598 A AU7222598 A AU 7222598A AU 7222598 A AU7222598 A AU 7222598A
Authority
AU
Australia
Prior art keywords
anxiety
depression
treatment
docosahexaenoic acid
natural antioxidants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72225/98A
Inventor
David Frederick Horrobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9708703.5A external-priority patent/GB9708703D0/en
Priority claimed from GBGB9708700.1A external-priority patent/GB9708700D0/en
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Publication of AU7222598A publication Critical patent/AU7222598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU72225/98A 1997-04-29 1998-04-23 Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants Abandoned AU7222598A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9708703 1997-04-29
GBGB9708703.5A GB9708703D0 (en) 1997-04-29 1997-04-29 Treatment of depression and anxiety
GB9708700 1997-04-29
GBGB9708700.1A GB9708700D0 (en) 1997-04-29 1997-04-29 Treatment of depression
PCT/GB1998/001260 WO1998048788A1 (en) 1997-04-29 1998-04-23 Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants

Publications (1)

Publication Number Publication Date
AU7222598A true AU7222598A (en) 1998-11-24

Family

ID=26311457

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72225/98A Abandoned AU7222598A (en) 1997-04-29 1998-04-23 Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants

Country Status (2)

Country Link
AU (1) AU7222598A (en)
WO (1) WO1998048788A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788437B1 (en) * 1999-01-14 2006-08-11 Inst Rech Biolog Sa NEW USE OF PLANT AND ANIMAL PHOSPHOLIPIDS IN NUTRITIONAL THERAPEUTICS
GB9901808D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Drugs for treatment of psychiatric and brain disorders
GB9904895D0 (en) * 1999-03-03 1999-04-28 Scarista Limited Regulators of coenzyme-A-independent transacylase as psychotropic drugs
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
NL1019368C2 (en) * 2001-11-14 2003-05-20 Nutricia Nv Preparation for improving receptor performance.
GB0202900D0 (en) * 2002-02-07 2002-03-27 Laxdale Ltd Novel formulations of drugs
US7282593B2 (en) 2003-09-11 2007-10-16 Board Of Trustees Of Michigan State University Withanamide and withanolide compositions and method of use thereof
AU2005208832A1 (en) * 2004-01-19 2005-08-11 Martek Biosciences Corporation Reelin deficiency or dysfunction and methods related thereto
AU2005244483B2 (en) * 2004-04-16 2011-06-09 Abbott Laboratories Gmbh Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease
EP1897530A1 (en) * 2006-09-08 2008-03-12 DSMIP Assets B.V. Skin care composition
WO2009099886A1 (en) * 2008-01-31 2009-08-13 Monsanto Technology Llc Methods of improving dha deposition and related function and/or development
KR102399290B1 (en) * 2014-05-08 2022-05-17 디에스엠 아이피 어셋츠 비.브이. Methods and compositions comprising 10-hydroxy-2-decenoic acid
WO2019238998A1 (en) * 2018-06-13 2019-12-19 Servicio Andaluz De Salud Use of antioxidants for the treatment of depression in older patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
FR2749133A1 (en) * 1996-06-04 1997-12-05 Pierre Moreau Production of phospholipid(s) which are rich in docosahexaenoic acid

Also Published As

Publication number Publication date
WO1998048788A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
AU6307698A (en) Useful properties of human lactoferrin and variants thereof
AU7133298A (en) Implantable medical device and method of manufacture
SG65631A1 (en) Preparation of acrylic acid and esters
AU9458398A (en) Balloon catheter and method of production thereof
PL323087A1 (en) Methods of and formulations for modulating human sexual response
AP2000001783A0 (en) Disinfectant and method of making
AU2071097A (en) Cannula and method of manufacture and use
AU7710198A (en) Single pass lead and method of use
AU7361396A (en) Biomedical adhesive electrode and method of use
AU1688495A (en) Reproduction and utilization of functional human tissue
AU4717301A (en) Catheter assembly and method of use
AU5315898A (en) Compositions for disinfection of skin and mucous membrane
AU3068699A (en) Skin equivalent and methods of forming and using same
AU7163798A (en) A novel dietary formulation comprising arachidonic acid and methods of use
AU7222598A (en) Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
AU2091099A (en) Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof
AU2058701A (en) Esters of vitamin D3 and uses thereof
AU8140998A (en) Development and use of human pancreatic cell lines
AU2058697A (en) Treatment of sleep disorders
AU2626895A (en) Production and uses of caffeic acid and derivatives thereof
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
AU6104896A (en) Therapeutic microdevices and methods of making and using sam e
PL341205A1 (en) Method of obtaining l-dihydroorotic acid and application thereof
PL322002A1 (en) Variants of human dnase i
EP1009433A4 (en) Therapeutic composition and method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase